CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 754 enrolled
Drug / intervention
Tiotropiumdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00615992
NCT00615992N/ACompleted
CompareCT.gov

Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines

Boehringer Ingelheim·observational·Posted Feb 14, 2008·Updated Feb 8, 2016

In Brief

An observational study evaluating Tiotropium for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 754 participants across 73 sites.

Detailed Summary

The primary goal of this post marketing surveillance (PMS) study is to document the efficacy of Tiotropium (Spiriva) to improve physical activity measured by a score that is recommended in national chronic obstructive pulmonary disease (COPD) guidelines for monitoring the course of the disease.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Disease, Chronic Obstructive
CountriesAustria
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 14, 2008
Enrollment StartApr 1, 2007
Primary CompletionApr 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 18.4 years ago

Interventions

Tiotropiumdrug